CD47 and neoplasm: Using subcutaneous xenograft models in NSG mice of CD47-overexpressing BCs, Kiss et al. (Kiss et al., 2019) showed that a single treatment with 200 μg of anti-CD47-IR700 followed by 100 J/cm2 (on day 1) and 50 J/cm2 (on day 2) of NIR-light resulted in a reduction of tumour growth compared with control mice receiving no treatment, anti-CD47-IR700 only or NIR-light only.